Skip to main content
JAMA Network logoLink to JAMA Network
. 2021 Sep 7;181(11):1537–1539. doi: 10.1001/jamainternmed.2021.4945

Age at Diagnosis of Diabetes by Race and Ethnicity in the United States From 2011 to 2018

Michael C Wang 1, Nilay S Shah 1,2, Mercedes R Carnethon 1, Matthew J O’Brien 1,3, Sadiya S Khan 1,2,
PMCID: PMC8424523  PMID: 34491260

Abstract

This cross-sectional study uses data from the National Health and Nutrition Examination Survey to assess age at diagnosis of diabetes by race/ethnicity in the US from 2011 to 2018.


The prevalence of diabetes in the US has increased substantially over the past 2 decades and is higher among non-Hispanic Black and Hispanic adults than non-Hispanic White adults.1 Earlier age at diabetes onset is associated with greater risk of cardiovascular disease and death2 and may contribute to observed racial/ethnic disparities in diabetes complications. Therefore, we compared the self-reported age at diabetes diagnosis by race/ethnicity in the US.

Methods

We performed a cross-sectional study pooling data from four 2-year cycles of the National Health and Nutrition Examination Survey, from January 1, 2011, to December 31, 2018. The Northwestern University institutional review board determined this study to be exempt from review and informed consent due to the use of deidentified data. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.

Data were combined starting with the 2011-2012 survey because that was the first cycle to include self-identified Asian respondents. We included all adults (aged ≥20 years) who self-reported a history of diabetes and age at diagnosis. Self-reported race/ethnicity was assessed as a social construct to investigate health disparities. We computed the mean and median age at diagnosis of diabetes overall and by race/ethnicity, examining group differences using t tests and quantile regression, respectively. We additionally determined the proportion of adults in each racial/ethnic group with age at diagnosis of diabetes before age 40, 35, and 30 years. In the primary analysis, we excluded adults with a likely diagnosis of type 1 diabetes, defined by self-report of diagnosis before age 30 years and on insulin monotherapy.3 In a sensitivity analysis, we included all adults with self-reported diabetes. All reported statistics are weighted to be representative of the civilian noninstitutionalized US population. All analyses accounted for the complex sampling design of the National Health and Nutrition Examination Survey. Statistical analyses were conducted from February 22 to June 23, 2021, using Stata, version 15.1 (StataCorp LLC). All P values were 2-sided, and P < .05 was considered statistically significant.

Results

The study sample included 3022 participants (1586 men and 1436 women; 946 non-Hispanic White participants; weighted mean [SD] age, 61.1 [0.3] years) who reported diabetes, representing 22 844 326 adults (Table 1). The mean age at diabetes diagnosis overall was 49.9 years (95% CI, 49.2-50.7 years) (Table 2). Relative to non-Hispanic White adults (mean age, 51.8 years; 95% CI, 50.8-52.9 years), Mexican American and non-Hispanic Black adults reported a significantly younger mean age at diagnosis (mean age, 47.2 years; 95% CI, 46.1-48.4 years and 44.9 years; 95% CI, 43.4-46.4 years, respectively; P < .001), but non-Hispanic Asian adults did not (mean age, 50.5 years; 95% CI, 48.4-52.6 years). The weighted proportion of adults with diabetes diagnosed before age 40 years was greater among Mexican American adults (35.0%) and non-Hispanic Black adults (25.1%) compared with non-Hispanic White adults (14.4%) (P ≤ .001). In the sensitivity analysis including all adults with self-reported diabetes, a similar pattern in age at diabetes diagnosis was observed.

Table 1. Demographic Characteristics of Adults With Self-reported Diabetes by Race and Ethnicity in the US, 2011-2018.

Characteristic Overall (N = 3022) Non-Hispanic White (n = 946) Non-Hispanic Black (n = 805) Mexican American (n = 508)a Non-Hispanic Asian (n = 339)
Weighted, No.b 22 844 326 13 613 262 3 295 576 2 252 173 1 334 882
Age, mean (SD)c 61.1 (0.3) 63.1 (0.4) 59.4 (0.5) 55.3 (0.9) 60.4 (1.0)
Women, % 48.3 46.3 57.2 49.5 48.2
Men, % 51.7 53.7 42.8 50.5 51.8
Education, %
Less than high school 21.8 14.2 24.6 55.1 23.4
High school graduate 25.5 26.9 25.8 21.5 15.8
Any college 52.7 58.9 49.6 23.3 60.8
Hypertension, %d 70.2 71.9 77.7 57.3 56.6
Obesity, %d 55.8 59.5 59.9 56.1 16.5
a

Oversampled relative to other Hispanic populations due to the National Health and Nutrition Examination Survey sampling design.

b

All statistics are weighted to be representative of the US population.

c

At time of survey.

d

Based on self-reported data.

Table 2. Distribution of Age at Diabetes Diagnosis by Race and Ethnicity in the United States, 2011-2018.

Variable Overall (N = 3022) Non-Hispanic White (n = 946) Non-Hispanic Black (n = 805) Mexican American (n = 508)a Non-Hispanic Asian (n = 339)
Summary measures of age at diabetes diagnosisb
Mean (95% CI) 49.9 (49.2-50.7) 51.8 (50.8-52.9) 47.2 (46.1-48.4) 44.9 (43.4-46.4) 50.5 (48.4-52.6)
P value for differencec NA 1 [Reference] <.001 <.001 .25
Median 50 52 48 45 50
P value for differencec,d NA 1 [Reference] <.001 <.001 .07
Proportion of adults with diabetes diagnosis at varying agesb
Diagnosis at <40 y, % 19.4 14.4 25.1 35.0 19.3
P value for differencec NA 1 [Reference] .001 <.001 .10
Diagnosis at <35 y, % 12.2 9.3 15.5 21.0 13.2
P value for differencec NA 1 [Reference] .006 <.001 .10
Diagnosis at <30 y, % 5.9 4.4 7.3 10.1 7.4
P value for differencec NA 1 [Reference] .06 .008 .14

Abbreviation: NA, not applicable.

a

Oversampled relative to other Hispanic populations owing to the National Health and Nutrition Examination Survey sampling design.

b

All statistics are weighted to be representative of the US population.

c

P values were calculated using the group with the oldest mean age at diagnosis as the referent (non-Hispanic White adults).

d

Based on quantile regression.

Discussion

In this cross-sectional study of a nationally representative sample of US adults from 2011-2018, the mean age at diabetes diagnosis was 4 to 7 years earlier in non-Hispanic Black and Mexican American adults than in non-Hispanic White adults. In addition, more than 25% of non-Hispanic Black and Mexican American adults with diagnosed diabetes reported diagnosis before age 40 years. The lack of observed differences between non-Hispanic White and non-Hispanic Asian adults may mask heterogeneity across different Asian subgroups.4 Additional limitations of this work include reliance on self-reported data, which are subject to recall bias and do not capture undiagnosed diabetes.

Earlier age at diabetes diagnosis among non-Hispanic Black and Mexican American adults is attributable to a combination of clinical, behavioral, and social factors5 and may potentially contribute to observed disparities in diabetes-related microvascular and macrovascular complications and premature mortality. Accordingly, there may be benefit to initiating intensive lifestyle changes starting earlier in adulthood.6 Efforts to prevent and manage diabetes earlier in the life course may help reduce the substantial premature morbidity and mortality associated with diabetes.

References

  • 1.Virani SS, Alonso A, Aparicio HJ, et al. ; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee . Heart disease and stroke statistics–2021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254-e743. doi: 10.1161/CIR.0000000000000950 [DOI] [PubMed] [Google Scholar]
  • 2.Nanayakkara N, Curtis AJ, Heritier S, et al. Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses. Diabetologia. 2021;64(2):275-287. doi: 10.1007/s00125-020-05319-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Koopman RJ, Mainous AG III, Diaz VA, Geesey ME. Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000. Ann Fam Med. 2005;3(1):60-63. doi: 10.1370/afm.214 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Cheng YJ, Kanaya AM, Araneta MRG, et al. Prevalence of diabetes by race and ethnicity in the United States, 2011-2016. JAMA. 2019;322(24):2389-2398. doi: 10.1001/jama.2019.19365 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Hill-Briggs F, Adler NE, Berkowitz SA, et al. Social determinants of health and diabetes: a scientific review. Diabetes Care. 2020;44(1):258-279. doi: 10.2337/dci20-0053 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Davidson KW, Barry MJ, Mangione CM, et al. ; US Preventive Services Task Force . Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement. JAMA. 2021;326(8):736-743. doi: 10.1001/jama.2021.12531 [DOI] [PubMed] [Google Scholar]

Articles from JAMA Internal Medicine are provided here courtesy of American Medical Association

RESOURCES